195 related articles for article (PubMed ID: 19686640)
1. The elastic properties of the Cryptococcus neoformans capsule.
Frases S; Pontes B; Nimrichter L; Rodrigues ML; Viana NB; Casadevall A
Biophys J; 2009 Aug; 97(4):937-45. PubMed ID: 19686640
[TBL] [Abstract][Full Text] [Related]
2. Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules.
Frases S; Pontes B; Nimrichter L; Viana NB; Rodrigues ML; Casadevall A
Proc Natl Acad Sci U S A; 2009 Jan; 106(4):1228-33. PubMed ID: 19164571
[TBL] [Abstract][Full Text] [Related]
3. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding.
Nosanchuk JD; Casadevall A
Infect Immun; 1997 May; 65(5):1836-41. PubMed ID: 9125569
[TBL] [Abstract][Full Text] [Related]
4. The Buoyancy of
Vij R; Cordero RJB; Casadevall A
mSphere; 2018 Nov; 3(6):. PubMed ID: 30404928
[No Abstract] [Full Text] [Related]
5. Rheological properties of cryptococcal polysaccharide change with fiber size, antibody binding and temperature.
de S Araújo GR; Viana NB; Pontes B; Frases S
Future Microbiol; 2019 Jul; 14():867-884. PubMed ID: 31340660
[No Abstract] [Full Text] [Related]
6. Molecular architecture of the Cryptococcus neoformans capsule.
Gates MA; Thorkildson P; Kozel TR
Mol Microbiol; 2004 Apr; 52(1):13-24. PubMed ID: 15049807
[TBL] [Abstract][Full Text] [Related]
7. The Capsule of Cryptococcus neoformans Modulates Phagosomal pH through Its Acid-Base Properties.
De Leon-Rodriguez CM; Fu MS; Çorbali MO; Cordero RJB; Casadevall A
mSphere; 2018 Oct; 3(5):. PubMed ID: 30355667
[TBL] [Abstract][Full Text] [Related]
8. Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties.
Cordero RJ; Pontes B; Frases S; Nakouzi AS; Nimrichter L; Rodrigues ML; Viana NB; Casadevall A
J Immunol; 2013 Jan; 190(1):317-23. PubMed ID: 23233725
[TBL] [Abstract][Full Text] [Related]
9. Variation in Cell Surface Hydrophobicity among Cryptococcus neoformans Strains Influences Interactions with Amoebas.
Vij R; Danchik C; Crawford C; Dragotakes Q; Casadevall A
mSphere; 2020 Apr; 5(2):. PubMed ID: 32350094
[No Abstract] [Full Text] [Related]
10. Exploring
Crawford CJ; Cordero RJB; Guazzelli L; Wear MP; Bowen A; Oscarson S; Casadevall A
J Biol Chem; 2020 Mar; 295(13):4327-4340. PubMed ID: 32005661
[TBL] [Abstract][Full Text] [Related]
11. The capsular dynamics of Cryptococcus neoformans.
McFadden D; Zaragoza O; Casadevall A
Trends Microbiol; 2006 Nov; 14(11):497-505. PubMed ID: 16996739
[TBL] [Abstract][Full Text] [Related]
12. Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis.
Yasuoka A; Kohno S; Yamada H; Kaku M; Koga H
Microbiol Immunol; 1994; 38(11):851-6. PubMed ID: 7898383
[TBL] [Abstract][Full Text] [Related]
13. The physical properties of the capsular polysaccharides from Cryptococcus neoformans suggest features for capsule construction.
McFadden DC; De Jesus M; Casadevall A
J Biol Chem; 2006 Jan; 281(4):1868-75. PubMed ID: 16278213
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
Kozel TR
Infect Immun; 1983 Mar; 39(3):1214-9. PubMed ID: 6341232
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.
Zaragoza O; Taborda CP; Casadevall A
Eur J Immunol; 2003 Jul; 33(7):1957-67. PubMed ID: 12884862
[TBL] [Abstract][Full Text] [Related]
16. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding.
Zaragoza O; Telzak A; Bryan RA; Dadachova E; Casadevall A
Mol Microbiol; 2006 Jan; 59(1):67-83. PubMed ID: 16359319
[TBL] [Abstract][Full Text] [Related]
17. Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.
Araujo Gde S; Fonseca FL; Pontes B; Torres A; Cordero RJ; Zancopé-Oliveira RM; Casadevall A; Viana NB; Nimrichter L; Rodrigues ML; Garcia ES; Souza Wd; Frases S
PLoS One; 2012; 7(1):e29561. PubMed ID: 22253734
[TBL] [Abstract][Full Text] [Related]
18. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.
Nimrichter L; Frases S; Cinelli LP; Viana NB; Nakouzi A; Travassos LR; Casadevall A; Rodrigues ML
Eukaryot Cell; 2007 Aug; 6(8):1400-10. PubMed ID: 17573547
[TBL] [Abstract][Full Text] [Related]
19. The Cryptococcus neoformans capsule: a sword and a shield.
O'Meara TR; Alspaugh JA
Clin Microbiol Rev; 2012 Jul; 25(3):387-408. PubMed ID: 22763631
[TBL] [Abstract][Full Text] [Related]
20. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.
van de Wetering JK; Coenjaerts FE; Vaandrager AB; van Golde LM; Batenburg JJ
Infect Immun; 2004 Jan; 72(1):145-53. PubMed ID: 14688091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
